{
    "organizations": [],
    "uuid": "ff9b0cc829d57f9b1162dd409e7478026998da04",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pernix-therapeutics-reports-q4-los/brief-pernix-therapeutics-reports-q4-loss-per-share-2-78-idUSASB0C9J2",
    "ord_in_thread": 0,
    "title": "BRIEF-Pernix Therapeutics Reports Q4 Loss Per Share $2.78",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Pernix Therapeutics Holdings Inc :\n* PERNIX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 REVENUE ROSE 38 PERCENT TO $41.5 MILLION * Q4 LOSS PER SHARE $2.78 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-09T05:22:00.000+02:00",
    "crawled": "2018-03-09T14:49:05.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "pernix",
        "therapeutic",
        "holding",
        "inc",
        "pernix",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}